Genpharmasec has informed that in continuation to intimation dated 19th September, 2023, wherein Genpharmasec (the Company) had made disclosures under Reg. 30 of the listing regulations, 2015 informing the execution of Share Purchase Agreement [SPA] and Share Subscription cum Shareholders Agreement [SSSA] in relation to acquire of 70% stake in Derren Healthcare in a staged manner, the Company has as on 11 March, 2024 acquired the 70% stake in Derren Healthcare. They are enclosing the information pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular number CIR/CFD/CMD/4/2015 dated 9th September, 2015 as Annexure-A.
The above information is a part of company’s filings submitted to BSE.